(Q33829703)

29 July 2017

1 reference

title

Epidemiology of nosocomial clostridium difficile diarrhoea (English)

1 reference

29 July 2017

0 references

Clostridium difficile

0 references

1 reference

Samore MH

1

1 reference

29 July 2017

1 December 1999

1 reference

Journal of Hospital Infection

29 July 2017

1 reference

29 July 2017

43 Suppl

1 reference

29 July 2017

S183-90

1 reference

INTESTINAL FLORA IN NEW-BORN INFANTS

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Pathogenesis of Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Clostridium difficile colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

The carrier state: Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Clostridium difficile infections of the gut: the unanswered questions

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Clostridium difficile--associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Clostridium difficile-associated disease in long-term care facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Infection due to Clostridium difficile among elderly residents of a long-term-care facility

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Medical implications of nosocomial infection with Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Management and control of a large outbreak of diarrhoea due to Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Clinical impact and associated costs of Clostridium difficile-associated disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Financial burden of hospital-acquired Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Clostridium difficile nosocomial infections--still lethal and persistent

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Risk factors for Clostridium difficile toxin-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Wide diversity of Clostridium difficile types at a tertiary referral hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Incidence and impact of Clostridium difficile infection in the UK, 1993-1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Application of a technique for serogrouping Clostridium difficile in an outbreak of antibiotic-associated diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Nosocomial Clostridium difficile colonisation and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Simultaneous outbreaks of two strains of toxigenic Clostridium difficile in a general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

A sustained outbreak of Clostridium difficile in a general hospital: persistence of a toxigenic clone in four units

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

The epidemiology and typing of Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Multicenter typing comparison of sporadic and outbreak Clostridium difficile isolates from geographically diverse hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Clostridium difficile colitis secondary to intravenous vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Epidemiology of Clostridium difficile-Induced Intestinal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Risk factors for Clostridium difficile cytotoxin-positive diarrhea after control for horizontal transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Antimicrobial associations of an outbreak of diarrhoea due to Clostridium difficile.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Epidemiology and prevention of Clostridium difficile infections in a leukemia unit

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Risk factors for Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Nosocomial acquisition of Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Clostridium difficile colonization and diarrhea at a tertiary care hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Effectiveness of liquid soap vs. chlorhexidine gluconate for the removal of Clostridium difficile from bare hands and gloved hands

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Inactivation of Clostridium difficile spores by disinfectants

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

A molecular characterization of Clostridium difficile isolates from humans, animals and their environments

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

The distribution of Clostridium difficile in the environment of South Wales.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Cleaning up Clostridium difficile infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Hospital-acquired Clostridium difficile diarrhoea and herd immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Acquisition of Clostridium difficile from the hospital environment

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990085-3

7 January 2021

10.1016/S0195-6701(99)90085-3

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10658778